Drawing for CLEARPATH DS-120

USPTO serial 85143029

CLEARPATH DS-120

Reviewed by CopyMark Law Group

Reg. 4150923Status 710
Filing date
Status date
Registration date
May 29, 2012
Examiner
THOMAS, JANICE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with CLEARPATH DS-120?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brendan M. Shortell

Brendan M. Shortell Lambert Shortell & Connaughton92 State StreetSuite 200Boston, MA 02109

Goods and services

ClassDescriptionStatusFirst use
010Non-invasive medical device used to detect ocular degradations that may cause blindness, cataract or other chronic disease due to elevated fluorescence in the lens of the eye measured against age related fluorescenceSECTION 8 - CANCELLEDFeb 10, 2010

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 22, 2020ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Apr 14, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 14, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 14, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 4, 2019C8..CANCELLED SEC. 8 (6-YR)—
May 29, 2017REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Feb 23, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 14, 2013ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 14, 2013REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 29, 2012R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 24, 2012SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Apr 23, 2012REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
Apr 16, 2012CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Apr 13, 2012SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Apr 13, 2012AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Mar 26, 2012IUAFUSE AMENDMENT FILED—
Mar 26, 2012EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Oct 18, 2011NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 23, 2011NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 23, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 21, 2011PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 19, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 18, 2011ACECAMENDMENT FROM APPLICANT ENTERED—
Jul 18, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 11, 2011ALIEASSIGNED TO LIE—
Jun 27, 2011MAILPAPER RECEIVED—
Jan 13, 2011GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 13, 2011GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 13, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 11, 2011DOCKASSIGNED TO EXAMINER—
Oct 6, 2010MPMKNOTICE OF PSEUDO MARK MAILED—
Oct 5, 2010NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 5, 2010NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance